RCL
66
-3
UNM
68
-4
CRM
49
2
HES
66
3
FE
48
2
CTSH
42
-2
HCP
62
8
CTAS
50
-2
MCK
55
2
MCHP
59
7
KMB
53
2
UHS
58
-4
JPM
64
2
GT
50
-2
EW
42
2
BAX
48
-2
WU
40
4
AN
52
-2
PEG
48
2
IPG
62
4
RCL
66
-3
UNM
68
-4
CRM
49
2
HES
66
3
FE
48
2
CTSH
42
-2
HCP
62
8
CTAS
50
-2
MCK
55
2
MCHP
59
7
KMB
53
2
UHS
58
-4
JPM
64
2
GT
50
-2
EW
42
2
BAX
48
-2
WU
40
4
AN
52
-2
PEG
48
2
IPG
62
4
Financhill
Back

BioXcel Therapeutics Vs. Vertex Pharmaceuticals Industry Stock Comparison

Sell
25

BTAI
BioXcel Therapeutics

Last Price:
2.71
Seasonality Move:
13.65%
Buy
60

VRTX
Vertex Pharmaceuticals

Last Price:
400.73
Seasonality Move:
11.79%
Sell
25
BioXcel Therapeutics (BTAI) is a Sell

Is BioXcel Therapeutics a Buy, Sell or Hold?

  • The current BioXcel Therapeutics [BTAI] share price is $2.71. The Score for BTAI is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • BTAI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Vertex Pharmaceuticals (VRTX) is a Buy

Is Vertex Pharmaceuticals a Buy, Sell or Hold?

  • The current Vertex Pharmaceuticals [VRTX] share price is $400.76. The Score for VRTX is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • VRTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BTAI Stock Price Chart

What is BioXcel Therapeutics's stock price today?

  • The BioXcel Therapeutics share price today is $2.71
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BTAI is experiencing selling pressure, which indicates risk of future bearish movement.

VRTX Stock Price Chart

What is Vertex Pharmaceuticals's stock price today?

  • The Vertex Pharmaceuticals share price today is $400.76
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRTX is experiencing selling pressure, which indicates risk of future bearish movement.

BTAI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 47.5 Sell
Chaikin Money Flow: -613073 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.64 - 2.86) Sell
Bollinger Bands (100): (2.61 - 3.37) Sell

VRTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.26 Sell
Relative Strength Index (14 RSI): 45.16 Sell
Chaikin Money Flow: -479527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (396.96 - 414.52) Sell
Bollinger Bands (100): (389.24 - 432.14) Sell

BTAI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.73 Sell
20-day SMA: 2.73 Sell
50-day SMA: 2.9 Sell
200-day SMA: 3.99 Sell
8-day EMA: 2.76 Sell
20-day EMA: 2.76 Sell
50-day EMA: 2.87 Sell
200-day EMA: 5.65 Sell

VRTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 397.22 Buy
20-day SMA: 403.28 Sell
50-day SMA: 412.52 Sell
200-day SMA: 383.01 Buy
8-day EMA: 399.39 Buy
20-day EMA: 402.58 Sell
50-day EMA: 408.04 Sell
200-day EMA: 385.6 Buy

BioXcel Therapeutics Earnings Growth & BTAI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.63 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.34 per share, and an increase next year of $1.29 per share.

Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.17 per share, an increase next quarter of $0.29 per share, an increase this year of $1.64 per share, and an increase next year of $1.39 per share.

BioXcel Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Vertex Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):